OTCMKTS:CURLF

Curaleaf Stock Forecast, Price & News

$14.40

+0.66 (+4.81 %)

(As of 05/14/2021 08:27 PM ET)

Add

Compare

Today's Range

$13.75

▼

$14.45

50-Day Range

$12.77

▼

$15.21

52-Week Range

$5.07

▼

$18.38

Volume547,257 shs

Average Volume1.30 million shs

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

30 days | 90 days | 365 days | Advanced Chart

Receive CURLF News and Ratings via Email

Sign-up to receive the latest news and ratings for Curaleaf and its competitors with MarketBeat's FREE daily newsletter.

About Curaleaf

Curaleaf Holdings, Inc. operates as an integrated medical and wellness cannabis operator in the United States. It operates in two segments, Cannabis Operations and Non-Cannabis Operations. The Cannabis Operations segment engages in the production and sale of cannabis through retail and wholesale channels. The Non-Cannabis Operations segment provides professional services, including cultivation, processing, and retail know-how and back office administration, intellectual property licensing, real estate leasing services, and lending facilities to medical and adult-use cannabis licensees under management service agreements. It offers oil-based formulations, such as vaporizing, cartridges, tinctures, and capsules; and ground-flower. The company also provides hemp-based CBD products. As of March 9, 2021, it operated 101 dispensaries, 23 cultivation sites, and 30 processing sites in 23 states of the United States. The company was founded in 2010 and is headquartered in Wakefield, Massachusetts.

Are These 3 Cannabis Stocks a Buy?
April 19, 2021 | marketbeat.com

Pot Companies' Hunt for New Markets Heats Up - Bloomberg
May 17, 2021 | bloomberg.com

Curaleaf to acquire Los Sueños Farms for $67 million in stock and cash - MarketWatch
May 17, 2021 | marketwatch.com

Curaleaf to Acquire Colorado-based Los Sueños
May 17, 2021 | finance.yahoo.com

How Curaleaf says it plans to invest in New York's small cannabis businesses - Albany Business Review - Albany Business Review
May 14, 2021 | bizjournals.com

Trulieve Cannabis Again Posts Industry-Leading Profits. Can They Continue?
May 13, 2021 | finance.yahoo.com

Curaleaf CEO: 2021 momentum points to a 'longer term trend' for cannabis - Yahoo Finance
May 13, 2021 | finance.yahoo.com

Is Curaleaf a Buy? - Motley Fool
May 13, 2021 | fool.com

Curaleaf International Launches Range of Medical Cannabis Products in Germany - Yahoo Finance
May 12, 2021 | finance.yahoo.com

Curaleaf Achieves Record Q1 Revenue Of $260M, Adjusted EBITDA, Exceeds Its Guidance - Benzinga
May 12, 2021 | benzinga.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Drug Manufacturers - Specialty & Generic

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:CURLF

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.curaleaf.com

Phone781-451-0150

EmployeesN/A

Year FoundedN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Miscellaneous

Outstanding SharesN/A

Market CapN/A

Next Earnings DateN/A

OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

1.62 out of 5 stars

Medical Sector

399th out of 2,032 stocks

Drug Manufacturers - Specialty & Generic Industry

4th out of 61 stocks

4.4 Analyst's Opinion

Consensus Rating
Curaleaf has received a consensus rating of Buy. The company's average rating score is 2.78, and is based on 8 buy ratings, no hold ratings, and 1 sell rating.
Price Target Upside/Downside
According to analysts' consensus price target of $22.50, Curaleaf has a forecasted upside of 56.3% from its current price of $14.40.
Amount of Analyst Coverage
Curaleaf has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

3.7 Community Rank

Outperform Votes
Curaleaf has received 123 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Curaleaf has received 43 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Curaleaf has received 74.10% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Curaleaf and other stocks. Vote “Outperform” if you believe CURLF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CURLF will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Curaleaf does not currently pay a dividend.
Dividend Growth
Curaleaf does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Curaleaf insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Curaleaf (OTCMKTS:CURLF) Frequently Asked Questions

Is Curaleaf a buy right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Curaleaf in the last twelve months. There are currently 1 sell rating and 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Curaleaf stock.
View analyst ratings for Curaleaf or view top-rated stocks.

What stocks does MarketBeat like better than Curaleaf?

Wall Street analysts have given Curaleaf a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Curaleaf wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were Curaleaf's earnings last quarter?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) announced its quarterly earnings results on Monday, March, 8th. The company reported ($0.05) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.02) by $0.03.
View Curaleaf's earnings history.

How has Curaleaf's stock price been impacted by COVID-19 (Coronavirus)?

Curaleaf's stock was trading at $4.42 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CURLF shares have increased by 225.8% and is now trading at $14.40.
View which stocks have been most impacted by COVID-19.

What price target have analysts set for CURLF?

9 Wall Street analysts have issued 1 year target prices for Curaleaf's stock. Their forecasts range from $16.00 to $32.25. On average, they anticipate Curaleaf's share price to reach $22.50 in the next year. This suggests a possible upside of 56.3% from the stock's current price.
View analysts' price targets for Curaleaf or view top-rated stocks among Wall Street analysts.

Who are Curaleaf's key executives?

Curaleaf's management team includes the following people:

Mr. Boris Alexis Jordan, Exec. Chairman (Age 55, Pay $750k)
Mr. Joseph F. Lusardi, Exec. Vice-Chairman (Age 46, Pay $1.01M)
Mr. Neil P. Davidson CPA, COO & Treasurer (Age 49, Pay $538.5k)
Mr. Joseph Daniel Bayern, Chief Exec. Officer (Age 58)
Mr. Christine Taylor, Sr. VP of Fin. & Accounting
Mr. Carlos Madrazo, Sr. VP of Investor Relations & Capital Markets
Mr. Peter Clateman, Chief Legal Officer (Age 53)
Mr. James S. Shorris, Chief Compliance Officer (Age 59)
Ms. Tracy Brady, VP of Corp. Communications
Ms. Carolyn Fedigan, Sr. VP of HR (Age 57)

Who are some of Curaleaf's key competitors?

Some companies that are related to Curaleaf include (THCX.V) (THCX), 31444 (GLH), 438280 (ACG), 815446 (HC), Abacus Health Products (ABAHF), Acreage (ACRGF), Althea Group (AGH), Applied Biosciences (APPB), AusCann Group (AC8), Ayr Strategies (AYRSF), Bio-Rad Laboratories (BIO), Blueberries Medical (BBM), Can B (CANB), Cannara Biotech (LOVE) and CannPal Animal Therapeutics (CP1).
View all of CURLF's competitors.

What is Curaleaf's stock symbol?

Curaleaf trades on the OTCMKTS under the ticker symbol "CURLF."

How do I buy shares of Curaleaf?

Shares of CURLF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Curaleaf's stock price today?

One share of CURLF stock can currently be purchased for approximately $14.40.

What is Curaleaf's official website?

The official website for Curaleaf is www.curaleaf.com.

How can I contact Curaleaf?

The company can be reached via phone at 781-451-0150.

This page was last updated on 5/17/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Curaleaf Stock Forecast, Price & News

Adding

Adding

Adding Curaleaf Holdings, Inc.

About Curaleaf

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

MarketRank™

Overall MarketRank™

4.4 Analyst's Opinion

Consensus Rating

Price Target Upside/Downside

Amount of Analyst Coverage

3.7 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment